Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia 2021-10-29 19:15
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom 2021-10-27 20:30
Novavax to Participate in World Vaccine Congress Europe 2021-10-16 04:39
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases 2021-09-24 08:47
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine 2021-09-23 21:59
Novavax to Participate in Fireside Chat at Devex @ UNGA 76 2021-09-21 04:46
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza 2021-09-08 20:30
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination 2021-08-06 05:03
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine 2021-08-06 04:41
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine 2021-08-04 21:10
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial 2021-06-15 07:06
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea 2021-05-23 00:39
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate 2021-05-10 21:55
Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility 2021-05-06 21:53
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover 2021-04-06 05:00
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials 2021-03-12 05:04
AGC Biologics Expands Partnership with Novavax 2020-08-11 04:20
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine 2020-06-03 19:00
1 2 3 4